contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
      researchContent {
        title
        lang
        pdfUrl
        relatedContent {
          __typename
          ...PublishingDetails
          ...Reactions
          id
        }
        content {
          title
          lang
          slug
          htmlBody
          publishedAt
          createdAt
          changedAt
          isOutdated
          isPremium
        }
      }
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Suominen is a manufacturing company. The company manufactures and develops a wide range of wipes, hygiene products and medical applications. The manufacturing is based on non-woven fabrics that can be used for various purposes. Customers are found in several industries, with the largest operations in Europe and North America. The company has its headquarters in Helsinki.

Here is a company report from Pauli regarding the rights issue.   Suominen is currently conducting a rights issue. We have updated the impact of the offering into our forecasts, but our operational assumptions remain unchanged. The issue will fund Suominen’s turnaround program, which we believe will help the company return to profitability in the coming years following recent losses. However, even considering this, the valuation remains expensive. We reiterate our Reduce recommendation and adjust our target price to EUR 0.6 (previously EUR 0.62, adjusted for the share issue).                    Inderes              Suominen: Osakeanti lukuihin, arvostus edelleen korkea - Inderes    Päivitimme annin vaikutukset ennusteisiimme, mutta operatiivisesti oletuksemme pysyivät ennallaan.

Here is Rauli’s interview. The video was filmed yesterday before the terms of the rights issue were released.

There hasn’t been any major chaos yet; the bid side is at 57 cents and the ask side is at 85 cents. Volume is starting to reach a decent level, and soon we’ll break the magical €1,000 limit in daily turnover.

It seems the stock is having some trouble finding its footing following the ex-rights date. As I noted in the comments, and as seen in the rights-adjusted price charts, the price based on yesterday’s close would now be 0.66 euros. Our target price has automatically updated to 0.62 euros, but I will be updating the rest of the figures shortly. We had a 25 MEUR hybrid bond in our model, so it is essentially just being replaced by a rights issue of a similar size.

Here are Rauli’s comments regarding the rights issue   Suominen announced on Monday the detailed terms for the approximately EUR 28 million rights issue it communicated in May. The size of the issue and the full subscription guarantee provided by the main owners were already known, so the new information consisted of the technical details of the issue, such as the subscription price, exchange ratio, and schedule. As we have previously estimated, the issue will significantly dilute the share capital. We will update our forecasts to reflect the new number of shares and the strengthening balance sheet in the near future.                    Inderes – 9 Jun 26              Suominen: Merkintäannin ehdot julki - Inderes    Merkintäanti laimentaa osakekantaa jopa 57 prosenttia ja tarjoaa uusia osakkeita 0,36 euron hintaan.

Personally, I don’t understand why they wouldn’t set the subscription price really low. It’s a completely different thing to get a full subscription commitment at a price of €0.05 versus €0.80. From the perspective of those subscribing for shares, it makes no difference whether the subscription price is €0.05 or €0.80.

An authorization is indeed an authorization, but why is such a large authorization being sought from the extraordinary general meeting? Even if the subscription price were around 20 cents, there would be 140 million new shares. That is a significant difference compared to a 500 million authorization. When you combine this with the subscription guarantee provided by the main owners for all potentially unsubscribed shares, it occurs to me that the subscription price will be set considerably low and the main owners are waiting with their hands out, should it not appeal to others…

Suominen

Suominen's Q1 comparable EBITDA fell short of Vara Research consensus expectations. The company continues to be impacted by low volumes, driven by incidents in the US in 2025, while it noted...

Suominen's Q1 comparable EBITDA fell short of Vara Research consensus expectations. The company continues to be impacted by low volumes, driven by incidents in the US in 2025, while it noted a partial recovery of these volumes from Q2. In the wake of increasing raw material and energy costs, the company has shortened pricing periods. In addition to successful pricing actions, the company needs to achieve success with its profitability improvement programme&nbsp;in order&nbsp;to finance required investments. We trim our estimates and derive a lower DCF- and multiples-based fair value range of EUR 0.8-1.4 (1.0-1.6).

Suominen: Still on a slippery path - Nordea

Suominen: Still on a slippery path - Nordea